Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ALC

Alcon (ALC)

Alcon Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ALC
DatumZeitQuelleÜberschriftSymbolFirma
12/11/202418h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
12/11/202418h09Business WireAlcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash GenerationNYSE:ALCAlcon Inc
07/11/202407h00Business WireAlcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week FreshNYSE:ALCAlcon Inc
04/11/202413h00Business WireAlgoma Central Corporation Reports Financial Results for the 2024 Third QuarterNYSE:ALCAlcon Inc
28/10/202402h00Business WireAlcon Singapore Elevates Associate Experience with Inspiring Engagement ProgramsNYSE:ALCAlcon Inc
15/10/202415h03Business WireAlcon Innovations on Display at AAO 2024 Demonstrate Efficiency and PerformanceNYSE:ALCAlcon Inc
12/09/202423h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
12/09/202421h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
09/09/202420h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
22/08/202417h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
20/08/202422h32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
20/08/202422h30Business WireAlcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact LensesNYSE:ALCAlcon Inc
02/08/202413h00Business WireAlgoma Central Corporation Reports Financial Results for the 2024 Second QuarterNYSE:ALCAlcon Inc
24/06/202407h00Business WireAlcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) ClearanceNYSE:ALCAlcon Inc
04/06/202419h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
04/06/202419h05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
29/05/202423h09Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ALCAlcon Inc
24/05/202420h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
17/05/202418h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
13/05/202422h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
13/05/202422h30Business WireAlcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular HealthNYSE:ALCAlcon Inc
08/05/202422h30Business WireAlcon Announces Results of 2024 Annual General MeetingNYSE:ALCAlcon Inc
01/05/202415h45Business WireAlgoma Central Corporation Reports Financial Results for the 2024 First QuarterNYSE:ALCAlcon Inc
07/04/202423h59Business WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
12/03/202409h30Business WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
06/03/202415h55Business WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
06/03/202415h55Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
06/03/202414h00Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
02/03/202400h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
29/02/202423h56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
 Showing the most relevant articles for your search:NYSE:ALC